Latest clinical trials News | Page 11

More women are using medical cannabis – but new research shows barriers push some into illegal markets
Mounjaro becomes available on the NHS: what to know and what to do if you’re not eligible
Preparations for the first CAR-T treatment for multiple myeloma in routine healthcare
First patient in Sweden with multiple myeloma prepared for CAR-T therapy in routine healthcare
Neuropathic pain has no immediate cause – research on a brain receptor may help stop this hard-to-treat condition
Stem cell manufacturing licence helps reduce Australia’s reliance on overseas bio-tech manufacturers
PolyU showcases innovative research in AI and medicine-engineering integration at BIO International Convention 2025
WHO issues first global guideline to improve pregnancy care for women with sickle cell disease
New Zealand psychiatrist granted approval to prescribe psilocybin
Equity and health: the inclusion of pregnant and breastfeeding women in clinical trials
New board members appointed to the Health Quality & Safety Commission
LabPMM® Receives New York State Approval for the NPM1 MRD Assay – Informing Therapy and Accelerating Targeted Trials
Government expands access to Melatonin and Psilocybin
RFK Jr’s Shakeup Of Vaccine Advisory Committee Raises Worries About Scientific Integrity Of Health Recommendations
World-first clinical trial to drug the ‘undruggable’ cancers
Welcoming Fleur O’Hare To CERA’s Consumer Program
AI Narrows Productivity Gap
Queensland counts more than 3800 women living with metastatic breast cancer, ending years of invisibility
Thesis on clinically reliable artificial intelligence for prostate cancer pathology
Fourth meeting of the International Health Regulations (2005) Emergency Committee regarding the upsurge of mpox 2024 – Temporary recommendations
US state passes law allowing experimental drugs to be prescribed – a model for the future?
Study reveals new indicators for HER2+ breast cancer response to therapy
Memories of the good parts of using drugs can keep people hooked − altering the neurons that store them could help treat addiction
Kanvas Biosciences Harnesses Power Of Microbiome
Is methylene blue really a brain booster? A pharmacologist explains the science
Byondis Announces First Patient Dosed in Phase 1 Clinical Trial of Novel SIRPa-Directed Monoclonal Antibody BYON4228 in Patients With Advanced or Metastatic Solid Tumors
Canine Genes Offer Clues To Gastric Cancer In Humans
AusBiotech welcomes announcement of Federal Shadow Ministry and encourages bipartisan support for Australia’s life sciences sector
Monash University to invest in a leading AI supercomputer to boost nation’s research capability: a first for Australia’s higher education sector
HistoSonics’ Edison Histotripsy System Gains Great Britain Early Market Access Under Unmet Clinical Needs Authorisation
Why we need testosterone products designed for women
‘Sage’ advice a Hit for future VR training solutions | University of Canterbury
RFK Jr. says annual COVID-19 shots no longer advised for healthy children and pregnant women – a public health expert explains the new guidance
A new treatment that can potentially change the outlook for patients with Alagille syndrome
From challenge to opportunity: Sector leaders chart the future of Australian medtech 
US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon HADLIMA(TM) (adalimumab-bwwd) Injection
Thesis On Groin Hernia Surgery In Women
Online Course Improves Sleep Quality By 40 Per Cent
Universal vaccines could reshape how we fight future outbreaks – but a broad approach is needed
How male anatomy became the default in medicine – and why that’s a problem
Too much sitting increases risk of future health problems in chest pain patients – new research
Message by the Director of the Department of Immunization, Vaccines and Biologicals at WHO – May 2025
NSW new clinical trials crucial for life of Brian and many others
NSW latest ground broken on $780 million Sydney Biomedical Accelerator
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 2025
Cell Painting identifies flavonoids that are toxic to bladder cancer cells
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 2025
AI tool accurately sorts cancer patients by their likely outcomes